Jw. Hou et al., AN EPIDEMIOLOGIC AND ETIOLOGIC STUDY OF CHILDREN WITH INTELLECTUAL DISABILITY IN TAIWAN, JIDR. Journal of intellectual disability research, 42, 1998, pp. 137-143
A large-scale cytogenetic study of the causes of intellectual disabili
ty (ID) in children from special schools and institutions was made in
Taiwan between 1991 and 1996. The screening methods and the identifica
tion of subjects with ID consisted of both clinical evaluation (i.e. p
hotographs, questionnaires on family, pre-, peri- and postnatal histor
y, and hospital records, including IQ) and further laboratory studies
for diagnosis (i.e. standard chromosome analysis, and if indicated, hi
gh-resolution banding, cytogenetic fragile-X study or molecular techni
ques). A total of 11892 patients were enrolled in this study. After ex
cluding the acquired causes of ID, such as infections and the sequelae
of brain insults, or the well-known single-gene disorders and other m
ultifactorial diseases, 4372 (36.8%) cumulative cases were recruited f
or karyotyping studies according to their phenotypes and medical recor
ds. Abnormal karyotypes were noted in 1889 children (43.2% of all sele
cted children). Thus, the overall incidence of chromosomal aberrations
in subjects with ID was estimated as 15.9%. Down's syndrome, the most
common cause of ID, accounted for 82.4% of all patients with abnormal
karyotypes. The causes of ID were considered to be prenatal in 55.2%
(n = 6564) of cases, perinatal in 9.5% (n = 1130), postnatal in 3.3% (
n = 392) and unknown in 32.0% (n = 3805) of cases. Two large groups we
re classified: (I) serious ID (37%), including profound, severe and mo
derate categories; and (2) mild ID (63%). The causes (pre-, peri- and
postnatal, and unknown) in these two populations were: 70%, 10.5%, 5.4
% and 14.1%, and 46.5%, 8.9%, 2.1% and 42.5%, respectively. Genetic ca
uses accounted for 38.5% (n = 4578) of all cases in this study, includ
ing 1557 with Down's syndrome, 233 with fragile-X syndrome, 199 with o
ther various chromosomal abnormalities (i.e. unbalanced translocation,
supernumerary markers and structural rearrangements), 238 with a defi
ned or presumed single-gene defect, and 98 with a recognized contiguou
s gene syndrome (Prader-Willi, 56; Angelman, 34; Williams, 5; and Kall
mann, 3); 2120 cases had familial ID. Multiple anomalies of undefined
pattern, but without chromosomal aberration, infantile autism, ID of n
ormal phenotype or family history, were of the other categories. Patie
nts with a single-gene disorder or chromosomal aberration, especially
those with unbalanced translocated or rearranged chromosomes, had gene
tic counselling and family studies. Pre-screening with photographs and
questionnaires may give a better costbenefit than blind mass cytogene
tic studies for each individual with ID.